ARCHIVES

Pretreatment with Azacitidine Achieves 28-Month Remission

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Five Center Core Grants Renewed

February 2, 1979

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds”

March 18, 1983